MASS 908 Devices Inc
- Stocks
- Healthcare
- NASDAQ: MASS
Price (delayed)
$8.1
Market cap
$292.29M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.54
Enterprise value
$234.97M
Relative Growth:
Rel. Growth:
69
Relative Strength:
Rel. Strength:
93
Relative Valuation:
Rel. Valuation:
12
Relative Profitability:
Rel. Profitability:
32
908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the U.S. Border Patrol selected the MX908® – a handheld, battery-powered,
Highlights
The EPS has surged by 53% year-on-year
MASS's revenue is up by 27% year-on-year and by 2.7% since the previous quarter
908 Devices's net income has soared by 51% YoY but it has decreased by 4.3% from the previous quarter
The quick ratio has declined by 37% since the previous quarter but it is up by 3.2% year-on-year
The gross margin has declined by 8% year-on-year
908 Devices's equity has decreased by 7% QoQ and by 4.8% YoY
Key stats
What are the main financial stats of MASS
Market
Valuations
Earnings
Shares outstanding
36.09M
Market cap
$292.29M
Enterprise value
$234.97M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.95
Price to sales (P/S)
4.81
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.89
Revenue
$60.41M
Gross profit
$29.35M
Operating income
-$80.58M
Net income
-$18.44M
EBIT
-$18.52M
EBITDA
-$13.4M
Free cash flow
-$29.28M
Per share
Balance sheet
Liquidity
EPS
-$0.54
EPS diluted
-$0.54
Free cash flow per share
-$0.82
Book value per share
$4.15
Revenue per share
$1.68
TBVPS
$4.3
Total assets
$191.7M
Total liabilities
$42.88M
Debt
$4.43M
Equity
$148.82M
Working capital
$118.16M
Debt to equity
0.03
Current ratio
4.98
Quick ratio
4.2
Net debt/EBITDA
4.28
Margins
Efficiency
Dividend
EBITDA margin
-22.2%
Gross margin
48.6%
Net margin
-30.5%
Operating margin
-133.4%
Return on assets
-10.2%
Return on equity
-13.3%
Return on invested capital
-30.3%
Return on capital employed
-11.4%
Return on sales
-30.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MASS stock price
How has the 908 Devices stock price performed over time
Intraday
4.52%
1 week
5.33%
1 month
-10.69%
1 year
121.31%
YTD
268.18%
QTD
-7.53%
Financial performance
How have 908 Devices's revenue and profit performed over time
Revenue
$60.41M
Gross profit
$29.35M
Operating income
-$80.58M
Net income
-$18.44M
Gross margin
48.6%
Net margin
-30.5%
908 Devices's operating income has shrunk by 130% YoY
MASS's operating margin has dropped by 81% year-on-year but it is up by 2.8% since the previous quarter
The company's net margin has surged by 62% YoY
908 Devices's net income has soared by 51% YoY but it has decreased by 4.3% from the previous quarter
Price vs fundamentals
How does MASS's price correlate with its fundamentals
Growth
What is 908 Devices's growth rate over time
Valuation
What is 908 Devices stock price valuation
P/E
N/A
P/B
1.95
P/S
4.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.89
The EPS has surged by 53% year-on-year
The P/B is 77% above the last 4 quarters average of 1.1 but 41% below the 5-year quarterly average of 3.3
908 Devices's equity has decreased by 7% QoQ and by 4.8% YoY
MASS's price to sales (P/S) is 85% higher than its last 4 quarters average of 2.6 but 60% lower than its 5-year quarterly average of 12.0
MASS's revenue is up by 27% year-on-year and by 2.7% since the previous quarter
Efficiency
How efficient is 908 Devices business performance
The return on sales has surged by 61% year-on-year
The ROIC has soared by 56% year-on-year
MASS's ROA is up by 46% YoY but it is down by 7% from the previous quarter
The company's return on equity rose by 43% YoY but it fell by 6% QoQ
Dividends
What is MASS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MASS.
Financial health
How did 908 Devices financials performed over time
The quick ratio has declined by 37% since the previous quarter but it is up by 3.2% year-on-year
The current ratio has declined by 35% since the previous quarter and by 2.2% year-on-year
The company's debt is 97% lower than its equity
MASS's debt to equity has surged by 50% since the previous quarter but it is down by 25% year-on-year
The company's debt fell by 21% YoY but it rose by 18% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.